This is the current revision of this page, as edited by Josve05a(talk | contribs) at 14:29, 20 August 2023(Alter: template type. Add: s2cid, doi, pages, issue, volume, journal, title, date, authors 1-10. | Use this tool. Report bugs. | #UCB_Gadget). The present address (URL) is a permanent link to this version.
Revision as of 14:29, 20 August 2023 by Josve05a(talk | contribs)(Alter: template type. Add: s2cid, doi, pages, issue, volume, journal, title, date, authors 1-10. | Use this tool. Report bugs. | #UCB_Gadget)
Acidic leucine-rich nuclear phosphoprotein 32 family member E is a protein that in humans is encoded by the ANP32Egene.[5][6] The ANP32E gene is located on chromosome 1q22.[5] In mammalian cells, ANP32E has been shown to be an H2A.Z chaperone capable of promoting the removal of H2A.Z from chromatin.[7] In brain tissue, ANP32E together with Cpd1 regulate protein phosphatase 2A activity at synapses during synaptogenesis[8] and has been observed to form a complex with ANP32A and SET that stabilizes short-lived mRNAs containing AU-rich elements, as well as having acetyltransferase inhibitory activity (in a complex with SET) and having a role in chromatin remodeling and transcriptional regulation.[9]
^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ abJiang M, Ma Y, Ni X, Cao G, Ji C, Cheng H, Tang R, Xie Y, Mao Y (Nov 2002). "Molecular cloning and characterization of a novel human gene (ANP32E alias LANPL) from human fetal brain". Cytogenet Genome Res. 97 (1–2): 68–71. doi:10.1159/000064058. PMID12438741. S2CID30549428.
^Obri A, Ouararhni K, Papin C, Diebold ML, Padmanabhan K, Marek M, Stoll I, Roy L, Reilly PT, Mak TW, Dimitrov S, Romier C, Hamiche A (2014). "ANP32E is a histone chaperone that removes H2A.Z from chromatin". Nature. 505 (7485): 648–53. Bibcode:2014Natur.505..648O. doi:10.1038/nature12922. PMID24463511. S2CID4406370.
^Costanzo RV, Vilá-Ortíz GJ, Perandones C, Carminatti H, Matilla A, Radrizzani M (2006). "Anp32e/Cpd1 regulates protein phosphatase 2A activity at synapses during synaptogenesis". Eur. J. Neurosci. 23 (2): 309–24. doi:10.1111/j.1460-9568.2005.04555.x. PMID16420440. S2CID46587416.
Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID8125298.
Radrizzani, M.; Vilá-Ortiz, G.; Cafferata, E. G.; Di Tella, M. C.; González-Guerrico, A.; Perandones, C.; Pivetta, O. H.; Carminatti, H.; Idoyaga Vargas, V. P.; Santa-Coloma, T. A. (2001). "Differential expression of CPD1 during postnatal development in the mouse cerebellum". Brain Research. 907 (1–2): 162–174. doi:10.1016/s0006-8993(01)02351-4. PMID11430900. S2CID29698240.
Radrizzani, M.; Brocardo, M. G.; Gonzalez Solveyra, C.; Bianchini, M.; Reyes, G. B.; Cafferata, E. G.; Vilá Ortiz, G.; Santa-Coloma, T. A. (2000). "Development of monoclonal oligobodies and chemically synthesized oligobodies". Medicina. 60 (Suppl 2): 55–60. PMID11188933.